IP Library Patent Application 12286185
Patent Application
App. No. 12/286,185

Use of beta-glucan on upper respiratory tract infection symptoms and psychological well-being

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/286,185
Abstract

Studies involving placebo-controlled, double-blinded designs to evaluate the effect of beta-glucan compositions on upper-respiratory tract infections and psychological wellness were carried out. During the course of the reporting periods of these studies, subjects in the treatment groups reported fewer URTI symptoms, better overall health and a more positive psychological assessment based on a POMS survey.

Claims (6)

1 . A method of reducing upper respiratory tract infection symptoms in stressed subjects, the method comprising:

administering an effective amount beta-glucan to the subject;

wherein the subject reports reduced symptoms associated with upper respiratory tract infections.

2 . A method of increasing a stressed subject's psychological well-being, the method comprising:

administering an effective amount of beta-glcuan to the subject;

wherein the subject reports increased psychological well-being.

Assignments (3)
SECURITY INTEREST Recorded Apr 8, 2015
From: BIOTHERA, INC.; LIFE SOURCE BASICS INC.; BIOTHERA HEALTH INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 035361/0929 →
CHANGE OF NAME Recorded May 23, 2011
From: BIOPOLYMER ENGINEERING, INC. D/B/A BIOTHERA
To: BIOTHERA, INC.
Reel/Frame 026325/0671 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2010
From: COX, DONALD J.; TALBOTT, SHAWN
To: BIOPOLYMER ENGINEERING, INC. DBA BIOTHERA
Reel/Frame 025442/0821 →